Skip to Content

Potassium Chloride Injection

Last Updated: January 19, 2018
Status: Current

Potassium Chloride Injection

Products Affected - Description
  • Potassium Chloride

Potassium chloride injection, Pfizer
2 mEq/mL, 5 mL vial, 25 count (NDC 00409-6635-01)
2 mEq/mL, 10 mL vial, 25 count (NDC 00409-6651-06)
2 mEq/mL, 250 mL bulk package 1 count (NDC 00409-1513-02)
 
Potassium Chloride in Dextrose
Potassium chloride injection, Pfizer
20 mEq/L, 5% dextrose 12 count (NDC 00409-7905-09)
 
Potassium Chloride in Dextrose and Lactated Ringers
Potassium chloride injection, Pfizer
20 mEq/L, 5% dextrose and lactated ringers 12 count (NDC 00409-7111-09)

Potassium Chloride in Dextrose and Sodium Chloride
Potassium chloride injection, Baxter
10 mEq/L, 5% dextrose and 0.45% sodium chloride 14 count (NDC 00338-0669-04)
20 mEq/L, 5% dextrose and 0.2% sodium chloride 14 count (NDC 00338-0663-04)
20 mEq/L, 5% dextrose and 0.9% sodium chloride 14 count (NDC 00338-0803-04)
40 mEq/L, 5% dextrose and 0.9% sodium chloride 14 count (NDC 00338-0807-04)
 
Potassium chloride injection, Pfizer
10 mEq/L, 5% dextrose and 0.45% sodium chloride 12 count (NDC 00409-7993-09)
20 mEq/L, 5% dextrose and 0.225% sodium chloride 12 count (NDC 00409-7901-09)
20 mEq/L, 5% dextrose and 0.45% sodium chloride 12 count (NDC 00409-7902-09)
20 mEq/L, 5% dextrose and 0.9% sodium chloride 12 count (NDC 00409-7107-09)
30 mEq/L, 5% dextrose and 0.45% sodium chloride 12 count (NDC 00409-7903-09)
40 mEq/L, 5% dextrose and 0.45% sodium chloride 12 count (NDC 00409-7904-09)
40 mEq/L, 5% dextrose and 0.9% sodium chloride 12 count (NDC 00409-7109-09)
10 mEq/500 mL, 5% dextrose and 0.225% sodium chloride 24 count (NDC 00409-7901-03)
10 mEq/500 mL, 5% dextrose and 0.45% sodium chloride 24 count (NDC 00409-7902-03)

Potassium Chloride in Sodium Chloride
Potassium chloride injection, Baxter
20 mEq/L, 0.45% sodium chloride 14 count (NDC 00338-0704-34)
 
Potassium chloride injection, Pfizer
20 mEq/L, 0.45% sodium chloride 12 count (NDC 00409-9257-39)
20 mEq/L, 0.9% sodium chloride 12 count (NDC 00409-7115-09)
40 mEq/L, 0.9% sodium chloride 12 count (NDC 00409-7116-09)

Potassium Chloride in Sterile Water
Potassium chloride injection, Baxter
10 mEq/50 mL, sterile water 24 count (NDC 00338-0705-41)
10 mEq/100 mL, sterile water 24 count (NDC 00338-0709-48)
20 mEq/50 mL, sterile water 24 count (NDC 00338-0703-41)
20 mEq/100 mL, sterile water 24 count (NDC 00338-0705-48)
40 mEq/100 mL, sterile water 24 count (NDC 00338-0703-48)
 
Potassium chloride injection, Pfizer
10 mEq/50 mL, sterile water 24 count (NDC 00409-7075-14)
10 mEq/100 mL, sterile water 24 count (NDC 00409-7074-26)
20 mEq/50 mL, sterile water 24 count (NDC 00409-7077-14)
20 mEq/100 mL, sterile water 24 count (NDC 00409-7075-26)
40 mEq/100 mL, sterile water 24 count (NDC 00409-7077-26)
Reason for the Shortage
    • Baxter has their highly concentrated potassium chloride in sterile water on shortage because a manufacturing facility has been affected by Hurricane Maria. Baxter has removed these products from distribution and they can be purchased directly if they are in stock. Baxter is also adjusting the allocation of these products. Baxter did not provide a reason for the shortage of their other potassium chloride products.
    • Fresenius Kabi did not provide a reason for the shortage.
    • Pfizer has potassium chloride injection on shortage due to increase demand and manufacturing delays.
Available Products
  • Potassium Chloride
    Potassium chloride injection, BBraun
    2 mEq/mL, 250 mL bulk package 1 count (NDC 00264-1940-20)

 
Potassium chloride injection, Fresenius Kabi
2 mEq/mL, 10 mL vial, 25 count (NDC 63323-0965-10)
2 mEq/mL, 20 mL vial, 25 count (NDC 63323-0965-20)
2 mEq/mL, 30 mL vial, 25 count (NDC 63323-0967-30)
 
Potassium chloride injection, Pfizer
2 mEq/mL, 10 mL vial, 25 count (NDC 00409-6651-06)
2 mEq/mL, 20 mL vial, 25 count (NDC 00409-6653-05)

Potassium Chloride in Dextrose
Potassium chloride injection, Baxter
20 mEq/L, 5% dextrose 14 count (NDC 00338-0683-04)

Potassium Chloride in Dextrose and Lactated Ringers
Potassium chloride injection, Baxter
20 mEq/L, 5% dextrose and lactated ringers 14 count (NDC 00338-0811-04)
 
Potassium Chloride in Dextrose and Sodium Chloride
Potassium chloride injection, Baxter
20 mEq/L, 5% dextrose and 0.45% sodium chloride 14 count (NDC 00338-0671-04)
30 mEq/L, 5% dextrose and 0.45% sodium chloride 14 count (NDC 00338-0673-04)
40 mEq/L, 5% dextrose and 0.45% sodium chloride 14 count (NDC 00338-0675-04)
20 mEq/500 mL, 5% dextrose and 0.2% sodium chloride 14 count (NDC 00338-0663-03)
20 mEq/500 mL, 5% dextrose and 0.45% sodium chloride 24 count (NDC 00338-0671-03)
 
Potassium Chloride in Sodium Chloride
Potassium chloride injection, Baxter
20 mEq/L, 0.9% sodium chloride 14 count (NDC 00338-0691-04)
40 mEq/L, 0.9% sodium chloride 14 count (NDC 00338-0695-04)

Estimated Resupply Dates

    • Baxter has potassium chloride 10 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride, potassium chloride 20 mEq/1000 mL in 5% dextrose and 0.2% sodium chloride, and potassium chloride 20 mEq/1000 mL in 0.45% sodium chloride available in limited quantities. Potassium chloride 20 mEq/1000 mL in 5% dextrose and 0.9% sodium chloride and potassium chloride 40 mEq/1000 mL in 5% dextrose and 0.9% sodium chloride on back order and the company cannot estimate a release date.
    • Baxter has all potassium chloride in sterile water presentations in sterile water on allocation.
    • Pfizer has potassium chloride 10 mEq/5 mL vials and 20mEq/10 mL vials on back order and the company estimates a release date of early-April 2018 for the 10 mEq/5 mL vials and late-March 2018 for the 20 mEq/10 mL vials.
    • ICU Medical has the 10 mEq/100 mL in sterile water, 20 mEq/50 mL in sterile water, 20 mEq/1000 mL in 0.9% sodium chloride premixed bags, and 20 mEq/1000 mL in lactated ringer's and 5% dextrose premixed bags on intermittent back order and the company is releasing supplies as they become available. Potassium chloride 10 mEq/500 mL in 5% dextrose and 0.225% sodium chloride premixed bags are on long-term back order. Several potassium chloride presentations are on allocation.

Safety

  • During this shortage, use oral therapy whenever possible to reserve remaining IV supplies. Compounding potassium-containing products poses significant safety risks. Consider oral therapy for patients with enteral or oral access and patients with potassium concentrations higher than 2.8 mmol/L.

Updated

January 19, 2018; December 18 and 6, November 21 and 17, October 25 and 4, September 13, August 15 and 8, July 14, June 20 and 2, May 9, April 4, March 27 and 13, February 7, 2017; November 29, September 21 and 9, August 10, July 7, June 8, May 4, March 11, January 27 and 4, 2016; December 23, 21 and 3, November 11, October 5, August 25, 20 and 12, July 16 and 2, May 21 and 11, April 8, March 23 and 9, February 19 and 2, January 14, 2015; December 10 and 2, November 12, October 23, September 24 and 5, August 6, July 17 and 2, May 29 and 22, April 15 and 1, March 14, February 27, January 22, 2014; December 13, November 7, October 26 and 1, September 12, August 27 and 10, July 26 and 6, June 13 and 1, May 30, 15 and 2, April 18, March 21 and 12, February 28, 2012, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide